6 completed, 6 recruiting, 5 unknown, 1 not yet recruiting. 7 Phase 3, 5 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Recruiting 2, Unknown 2 |
| Phase 4 | 5 | Recruiting 2, Unknown 2, Completed 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Left Ventricular Thrombus: new trials by email Literature Review of Left Ventricular Thrombus trials Research Report on Left Ventricular Thrombus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus Continue rivaroxaban or apixaban or warfarin, Discontinue rivaroxaban or apixaban or warfarin - Left Ventricular Thrombus | Phase 2 | Not yet recruiting | Queen Mary University of London | 120 | 2026-12-01 | 2026-02-27 |
| Apixaban Versus Warfarin for Left Ventricular Thrombus Apixaban, Warfarin - Left Ventricular Thrombus | Phase 3 | Recruiting | University of Arizona | 218 | 2026-06-22 | 2026-07-17 |
| Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction Apixaban, Warfarin - Left Ventricular Thrombus, Acute Myocardial Infarction | Phase 4 | Recruiting | Karolinska Institutet | 212 | 2025-04-08 | 2025-07-01 |
| Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction Apixaban 2.5 MG PO BID, Control (Standard treatment) - Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus | Phase 3 | Recruiting | National Institute of Cardiovascular Diseases, Pakistan | 472 | 2024-12-02 | 2024-12-19 |
| Left Ventricular Thrombus Registry Left Ventricular Thrombus | Recruiting | Queen Mary University of London | 1500 | 2024-05-17 | 2026-07-16 | |
| Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy Primary percutaneous coronary intervention or thrombolytic therapy - Left Ventricular Thrombus | Unknown | Assiut University | 400 | 2024-01-01 | 2023-12-01 | |
| Anticoagulation in Post MI LV Thrombus Trial in Nepal Rivaroxaban, Warfarin - Left Ventricular Thrombus, Myocardial Infarction | Phase 4 | Recruiting | Shahid Gangalal National Heart Centre | 196 | 2023-06-19 | 2025-05-11 |
| Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction Rivaroxaban 15 MG [Xarelto] - ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus | Not applicable | Recruiting | Jilin University | 320 | 2023-05-01 | 2026-06-01 |
| Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial Warfarin, Rivaroxaban 20 MG Oral Tablet, Apixaban 5mg or 2.5mg oral tablet - Left Ventricular Thrombus | Phase 4 | Unknown | Peshawar Institute of Cardiology | 141 | 2023-05-01 | 2023-08-02 |
| Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Rivaroxaban 2.5 MG [Xarelto], DAPT strategy - Myocardial Infarction, Acute, Left Ventricular Thrombus | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 560 | 2021-10-10 | 2024-07-10 |
| Rivaroxaban in Left Ventricular Thrombus Rivaroxaban, Warfarin - Acute Coronary Syndrome, Left Ventricular Thrombus | Phase 4 | Completed | National Institute of Cardiovascular Diseases, Pakistan | 261 | 2021-06-25 | 2024-11-15 |
| Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI Rivaroxaban 15 MG, Warfarin - Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction | Phase 3 | Completed | Rajaie Cardiovascular Medical and Research Center | 50 | 2020-07-30 | 2023-04-07 |
| Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus Combination of antiplatelet drugs and anticoagulants for at least one month - Acute Myocardial Infarction, Left Ventricular Thrombus | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 120 | 2020-06-01 | 2020-02-11 |
| Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant Rivaroxaban, Vitamin K Antagonist - ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus | Phase 3 | Unknown | RenJi Hospital | 280 | 2020-02-01 | 2023-06-01 |
| The "MyoThrombus" Study 18F-GP1 PET/MR - Left Ventricular Thrombus, Thrombosis | Completed | University of Edinburgh | 100 | 2020-01-02 | 2026-03-17 | |
| Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Rivaroxaban - ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus | Phase 3 | Unknown | RenJi Hospital | 200 | 2019-04-01 | 2018-12-26 |
| Apixaban in Patients With Left Ventricular Thrombus Apixaban, Warfarin - Left Ventricular Thrombus | Phase 3 | Completed | Saud Al Babtain Cardiac Center | 50 | 2018-02-18 | 2022-01-26 |
| Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction inflammatory indexes and CHA2DS2-VASc score - Left Ventricular Thrombus, Acute Anterior Myocardial Infarction | Completed | Henan Provincial People's Hospital | 371 | 2014-01-01 | 2021-05-04 |
ST Elevation Myocardial Infarction (5) · Thrombosis (3) · Anterior Wall Myocardial Infarction (2) · Myocardial Infarction (2) · Stroke (2) · Ventricular Dysfunction, Left (2) · Acute Coronary Syndrome (1)
Cardiovascular Diseases (12) · Vascular Diseases (12) · Heart Diseases (10) · Myocardial Ischemia (10) · Infarction (9) · Ischemia (9) · Necrosis (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Myocardial Infarction (7) · Embolism and Thrombosis (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2)
Rivaroxaban (8) · Warfarin (8) · apixaban (6) · Anticoagulants (1) · Tablets (1) · Thrombolytic Therapy (1) · Vitamin B 6 (1) · acarboxyprothrombin (1)
National Institute of Cardiovascular Diseases, Pakistan (2) · Queen Mary University of London (2) · RenJi Hospital (2) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Henan Provincial People's Hospital (1) · Jilin University (1) · Karolinska Institutet (1) · Peshawar Institute of Cardiology (1) · Rajaie Cardiovascular Medical and Research Center (1) · Saud Al Babtain Cardiac Center (1) · Shahid Gangalal National Heart Centre (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University of Arizona (1) · University of Edinburgh (1)
China (3) · Pakistan (3) · United Kingdom (3) · France (1) · Iran (1) · Nepal (1) · Saudi Arabia (1) · Sweden (1) · United States (1)
Ihsan Ullah, MD (1) · Jehangir A Shah, FCPS (1) · Mingyou Zhang (1) · Moa Simonsson, MD, PhD (1) · Parham Sadeghipour, M.D (1)
PMID 32355836, PMID 33766266, PMID 37716448, PMID 39773831, PMID 40706143, PMID 41739450